Limits on health-care resources mandate that resource-allocation decisions be guided by considerations of cost in relation to expected benefits. In cost-effectiveness analysis, the ratio of net health-care costs to net health benefits provides an index by which priorities may be set. Quality-of-life concerns, including both adverse and beneficial effects of therapy, may be incorporated in the calculation of health benefits as adjustments to life expectancy. The timing of future benefits and costs may be accounted for by the appropriate use of discounting. Current decisions must inevitably be based on imperfect information, but sensitivity analysis can increase the level of confidence in some decisions while suggesting areas where further research may be valuable in guiding others. Analyses should be adaptable to the needs of various health-care decision makers, including planners, administrators and providers.
This article has been cited by other articles:
Sharifi, E., Sharifi, H., Morshed, S., Bozic, K., Diab, M.
(2008). Cost-Effectiveness Analysis of Periacetabular Osteotomy. JBJS
90: 1447-1456
[Abstract][Full Text]
Schlander, M
(2008). The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process. J. Med. Ethics
34: 534-539
[Abstract][Full Text]
Bravo Vergel, Y., Sculpher, M.
(2008). Quality-adjusted life years. PN
8: 175-182
[Abstract][Full Text]
Shermock, K. M., Horn, E., Rice, T. L.
(2008). Erythropoietic agents for anemia of critical illness. Am J Health Syst Pharm
65: 540-546
[Abstract][Full Text]
Shechter, S. M., Bailey, M. D., Schaefer, A. J., Roberts, M. S.
(2008). The Optimal Time to Initiate HIV Therapy Under Ordered Health States. Operations Research
56: 20-33
[Abstract]
Krabbe, P. F. M., Salomon, J. A., Murray, C. J. L.
(2007). Quantification of Health States with Rank-Based Nonmetric Multidimensional Scaling. Med Decis Making
27: 395-405
[Abstract]
Myers, J., McCabe, S., Gohmann, S.
(2007). Quality-of-Life Assessment When There Is a Loss of Income. Med Decis Making
27: 27-33
[Abstract]
Hilty, D. M., Benjamin, S., Briscoe, G., Hales, D. J., Boland, R. J., Luo, J. S., Chan, C. H., Kennedy, R. S., Karlinsky, H., Gordon, D. B., Yellowlees, P. M., Yager, J.
(2006). APA Summit on Medical Student Education Task Force on Informatics and Technology: Steps to Enhance the Use of Technology in Education Through Faculty Development, Funding and Change Management. Acad. Psychiatry
30: 444-450
[Abstract][Full Text]
Gray, A. M
(2006). Cost-effectiveness analyses alongside randomised clinical trials. Clin Trials
3: 538-542
[Abstract]
Ryan, J., Cohen, D. J.
(2006). Are Drug-Eluting Stents Cost-Effective?: It Depends on Whom You Ask. Circulation
114: 1736-1744
[Full Text]
Soohoo, N. F., Sharifi, H., Kominski, G., Lieberman, J. R.
(2006). Cost-Effectiveness Analysis of Unicompartmental Knee Arthroplasty as an Alternative to Total Knee Arthroplasty for Unicompartmental Osteoarthritis. JBJS
88: 1975-1982
[Abstract][Full Text]
Hoel, M.
(2006). Cost-Effectiveness Analysis in the Health Sector when There is a Private Alternative to Public Treatment. CESifo Economic Studies
52: 500-512
[Abstract][Full Text]
Vergnenegre, A., Combescure, C., Fournel, P., Bayle, S., Gimenez, C., Souquet, P. J., Lena, H., Perol, M., Delhoume, J. Y., GFPC (Groupe Francais de Pneumo-Cancerologie),
(2006). Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95-01). Ann Oncol
17: 1269-1274
[Abstract][Full Text]
Paskett, E. D., Schrag, D., Kornblith, A., Lamont, E. B., Weeks, J. C., Marshall, J. R., Shapiro, C., Holland, J.
(2006). Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments.. Clin. Cancer Res.
12: 3601s-3605s
[Abstract][Full Text]
Reilly, B. M., Evans, A. T.
(2006). Translating Clinical Research into Clinical Practice: Impact of Using Prediction Rules To Make Decisions. ANN INTERN MED
144: 201-209
[Abstract][Full Text]
Firoz, B. F., Lee, S. J., Nghiem, P., Qureshi, A. A.
(2006). Role of Skin Biopsy to Confirm Suspected Acute Graft-vs-Host Disease: Results of Decision Analysis.. Arch Dermatol
142: 175-182
[Abstract][Full Text]
Sejean, K., Calmus, S., Durand-Zaleski, I., Bonnichon, P., Thomopoulos, P., Cormier, C., Legmann, P., Richard, B., Bertagna, X. Y, Vidal-Trecan, G. M
(2005). Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol
153: 915-927
[Abstract][Full Text]
Gupta, V, Srinivasan, G, Mei, S S, Gazzard, G, Sihota, R, Kapoor, K S
(2005). Utility values among glaucoma patients: an impact on the quality of life. Br. J. Ophthalmol.
89: 1241-1244
[Abstract][Full Text]
Brouwer, W. B F, Niessen, L. W, Postma, M. J, Rutten, F. F H
(2005). Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ
331: 446-448
[Full Text]
Garland, A.
(2005). Improving the ICU: Part 1. Chest
127: 2151-2164
[Abstract][Full Text]
Simunovic, M., Gafni, A., Levine, M.
(2005). In Reply:. JCO
23: 3633-3634
[Full Text]
Gazelle, G. S., McMahon, P. M., Siebert, U., Beinfeld, M. T.
(2005). Cost-effectiveness Analysis in the Assessment of Diagnostic Imaging Technologies. Radiology
235: 361-370
[Abstract][Full Text]
Baxter, Y. C., Dias, M. C. G., Maculevicius, J., Cecconello, I., Cotteleng, B., Waitzberg, D. L.
(2005). Economic Study in Surgical Patients of a New Model of Nutrition Therapy Integrating Hospital and Home vs the Conventional Hospital Model. JPEN J Parenter Enteral Nutr
29: S96-S105
[Abstract][Full Text]
Wakker, P. P., Jansen, S. J. T., Stiggelbout, A. M.
(2004). Anchor Levels as a New Tool for the Theory and Measurement of Multiattribute Utility. Decision Analysis
1: 217-234
[Abstract]
Kocher, M. S., Bishop, J. A., Hresko, M. T., Millis, M. B., Kim, Y.-J., Kasser, J. R.
(2004). Prophylactic Pinning of the Contralateral Hip After Unilateral Slipped Capital Femoral Epiphysis. JBJS
86: 2658-2665
[Abstract][Full Text]
Gray, D. T.
(2004). Neonatal Circumcision: Cost-Effective Preventive Measure or "the Unkindest Cut of All"?. Med Decis Making
24: 688-692
SooHoo, N. F., Kominski, G.
(2004). Cost-Effectiveness Analysis of Total Ankle Arthroplasty. JBJS
86: 2446-2455
[Abstract][Full Text]
Alagoz, O., Maillart, L. M., Schaefer, A. J., Roberts, M. S.
(2004). The Optimal Timing of Living-Donor Liver Transplantation. Management Science
50: 1420-1430
[Abstract]
Salomon, J. A, Weinstein, M. C, Goldie, S. J
(2004). Taking account of future technology in cost effectiveness analysis. BMJ
329: 733-736
[Full Text]
Kocher, M. S., Zurakowski, D.
(2004). Clinical Epidemiology and Biostatistics: A Primer for Orthopaedic Surgeons. JBJS
86: 607-620
[Full Text]
Greenberg, D., Bakhai, A., Cohen, D. J.
(2004). Can we afford to eliminate restenosis?: Can we afford not to?. J Am Coll Cardiol
43: 513-518
[Abstract][Full Text]
Minelli, C., Abrams, K. R, Sutton, A. J, Cooper, N. J
(2004). Benefits and harms associated with hormone replacement therapy: clinical decision analysis. BMJ
328: 371-
[Abstract][Full Text]
Simunovic, M., Gafni, A., Levine, M.
(2004). Economics of Preoperative Radiotherapy With Total Mesorectal Excision: What Can We Learn From the Dutch Experience?. JCO
22: 217-219
[Full Text]
Medina, L. S., Aguirre, E., Bernal, B., Altman, N. R.
(2004). Functional MR Imaging versus Wada Test for Evaluation of Language Lateralization: Cost Analysis. Radiology
230: 49-54
[Abstract][Full Text]
Andreoli, P. B. d. A., Citero, V. d. A., Mari, J. d. J.
(2003). A Systematic Review of Studies of the Cost-Effectiveness of Mental Health Consultation-Liaison Interventions in General Hospitals. Psychosomatics
44: 499-507
[Abstract][Full Text]
Arnesen, T M, Norheim, O F
(2003). Quantifying quality of life for economic analysis: time out for time trade off. Med. Humanities
29: 81-86
[Abstract][Full Text]
Stiell, I., Nichol, G., Wells, G., De Maio, V., Nesbitt, L., Blackburn, J., Spaite, D., for the OPALS Study Group,
(2003). Health-Related Quality of Life Is Better for Cardiac Arrest Survivors Who Received Citizen Cardiopulmonary Resuscitation. Circulation
108: 1939-1944
[Abstract][Full Text]
Sisk, J. E., Whang, W., Butler, J. C., Sneller, V.-P., Whitney, C. G.
(2003). Cost-Effectiveness of Vaccination against Invasive Pneumococcal Disease among People 50 through 64 Years of Age: Role of Comorbid Conditions and Race. ANN INTERN MED
138: 960-968
[Abstract][Full Text]
Gafni, A., Birch, S.
(2003). Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures?. CMAJ
168: 849-851
[Full Text]
Goyen, M., Herborn, C. U., Kroger, K., Lauenstein, T. C., Debatin, J. F., Ruehm, S. G.
(2003). Detection of Atherosclerosis: Systemic Imaging for Systemic Disease with Whole-Body Three-dimensional MR Angiography-- Initial Experience. Radiology
227: 277-282
[Abstract][Full Text]
Gray, D. T., Veenstra, D. L.
(2003). Comparative economic analyses of minimally invasive direct coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg.
125: 618-624
[Abstract][Full Text]
Mokrzycki, M. H., Singhal, A.
(2002). Cost-effectiveness of three strategies of managing tunnelled, cuffed haemodialysis catheters in clinically mild or asymptomatic bacteraemias. Nephrol Dial Transplant
17: 2196-2203
[Abstract][Full Text]
Chakravorty, I., Cayton, R.M., Szczepura, A.
(2002). Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome. Eur Respir J
20: 1233-1238
[Abstract][Full Text]
Capomolla, S., Febo, O., Ceresa, M., Caporotondi, A., Guazzotti, G., La Rovere, M. T., Ferrari, M., Lenta, F., Baldin, S., Vaccarini, C., Gnemmi, M., Pinna, G., Maestri, R., Abelli, P., Verdirosi, S., Cobelli, F.
(2002). Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol
40: 1259-1266
[Abstract][Full Text]
Medina, L. S., Richardson, R. R., Crone, K.
(2002). Children with Suspected Craniosynostosis: A Cost-Effectiveness Analysis of Diagnostic Strategies. Am. J. Roentgenol.
179: 215-221
[Abstract][Full Text]
Bree, R. L., Carlos, R. C.
(2002). US for Postmenopausal Bleeding: Consensus Development and Patient-centered Outcomes. Radiology
222: 595-598
[Full Text]
Bonneux, L
(2002). How to measure the burden of mortality?. J. Epidemiol. Community Health
56: 128-131
[Abstract][Full Text]
Stein, K, Rosenberg, W, Wong, J
(2002). Cost effectiveness of combination therapy for hepatitis C: a decision analytic model. Gut
50: 253-258
[Abstract][Full Text]
Sonnenberg, A., Delco, F.
(2002). Cost-effectiveness of a Single Colonoscopy in Screening for Colorectal Cancer. Arch Intern Med
162: 163-168
[Abstract][Full Text]
Esnaola, N. F., Lazarides, S. N., Mentzer, S. J., Kuntz, K. M.
(2002). Outcomes and Cost-Effectiveness of Alternative Staging Strategies for Non-Small-Cell Lung Cancer. JCO
20: 263-273
[Abstract][Full Text]
Blackmore, C. C., Zelman, W. N., Glick, N. D.
(2001). Resource Cost Analysis of Cervical Spine Trauma Radiography. Radiology
220: 581-587
[Abstract][Full Text]
Weinstein, M. C
(2001). Should physicians be gatekeepers of medical resources?. J. Med. Ethics
27: 268-274
[Abstract][Full Text]
Medina, L. S., Kuntz, K. M., Pomeroy, S.
(2001). Children With Headache Suspected of Having a Brain Tumor: A Cost-Effectiveness Analysis of Diagnostic Strategies. Pediatrics
108: 255-263
[Abstract][Full Text]
Singer, M. E., Applegate, K. E.
(2001). Cost-Effectiveness Analysis in Radiology. Radiology
219: 611-620
[Abstract][Full Text]
Gaynon, P. S., Bostrom, B. C., Hutchinson, R. J., Lange, B. J., Nachman, J. B., Steinherz, P. G., Sensel, M. G., Lee, M. K., Stram, D. O., Sather, H. N.
(2001). Duration of Hospitalization as a Measure of Cost on Children's Cancer Group Acute Lymphoblastic Leukemia Studies. JCO
19: 1916-1925
[Abstract][Full Text]
Brown, M. M, Brown, G. C, Sharma, S., Kistler, J., Brown, H.
(2001). Utility values associated with blindness in an adult population. Br. J. Ophthalmol.
85: 327-331
[Abstract][Full Text]
Bonneux, L, Birnie, E
(2001). The discount rate in the economic evaluation of prevention: a thought experiment. J. Epidemiol. Community Health
55: 123-125
[Abstract][Full Text]
Phillips, K. A., Shlipak, M. G., Coxson, P., Heidenreich, P. A., Hunink, M. G. M., Goldman, P. A., Williams, L. W., Weinstein, M. C., Goldman, L.
(2000). Health and Economic Benefits of Increased {beta}-Blocker Use Following Myocardial Infarction. JAMA
284: 2748-2754
[Abstract][Full Text]
Lehoux, P., Blume, S.
(2000). Technology Assessment and the Sociopolitics of Health Technologies. Journal of Health Politics, Policy and Law
25: 1083-1120
[Abstract]
Holloway, R. G., Ringel, S. P., Bernat, J. L., Keran, C. M., Lawyer, B. L.
(2000). US neurologists: Attitudes on rationing. Neurology
55: 1492-1497
[Abstract][Full Text]
Sonnenberg, A., Delco, F., Inadomi, J. M.
(2000). Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer. ANN INTERN MED
133: 573-584
[Abstract][Full Text]
Schopper, D, Pereira, J, Torres, A, Cuende, N, Alonso, M, Baylin, A, Ammon, C, Rougemont, A
(2000). Estimating the burden of disease in one Swiss canton: what do disability adjusted life years (DALY) tell us?. Int J Epidemiol
29: 871-877
[Abstract][Full Text]
Selmer, R. M, Kristiansen, I. S., Haglerød, A., Graff-Iversen, S., Larsen, H. K, Meyer, H. E, Bønaa, K. H, Thelle, D. S
(2000). Cost and health consequences of reducing the population intake of salt. J. Epidemiol. Community Health
54: 697-702
[Abstract][Full Text]
Neumann, P. J., Stone, P. W., Chapman, R. H., Sandberg, E. A., Bell, C. M.
(2000). The Quality of Reporting in Published Cost-Utility Analyses, 1976-1997. ANN INTERN MED
132: 964-972
[Abstract][Full Text]
Rennie, D., Luft, H. S.
(2000). Pharmacoeconomic Analyses: Making Them Transparent, Making Them Credible. JAMA
283: 2158-2160
[Full Text]
Delco, F, Sonnenberg, A
(2000). A decision analysis of surveillance for colorectal cancer in ulcerative colitis. Gut
46: 500-506
[Abstract][Full Text]
Rubin, G. D., Armerding, M. D., Dake, M. D., Napel, S.
(2000). Cost Identification of Abdominal Aortic Aneurysm Imaging by Using Time and Motion Analyses. Radiology
215: 63-70
[Abstract][Full Text]
Jarvik, J. G., Ramsey, S.
(2000). Radiographic Screening for Orbital Foreign Bodies Prior to MR Imaging: Is It Worth It?. Am. J. Neuroradiol.
21: 245-248
[Full Text]
Seidenwurm, D. J., McDonnell III, C. H., Raghavan, N., Breslau, J.
(2000). Cost Utility Analysis of Radiographic Screening for an Orbital Foreign Body before MR Imaging. Am. J. Neuroradiol.
21: 426-433
[Abstract][Full Text]
Brown, G. C., Brown, M. M., Sharma, S., Tasman, W., Brown, H. C.
(1999). Cost-Effectiveness of Treatment for Threshold Retinopathy of Prematurity. Pediatrics
104: 47e-47
[Abstract][Full Text]
Rich, M. W., Nease, R. F.
(1999). Cost-effectiveness Analysis in Clinical Practice: The Case of Heart Failure. Arch Intern Med
159: 1690-1700
[Abstract][Full Text]
Gross, C. P., Anderson, G. F., Powe, N. R.
(1999). The Relation between Funding by the National Institutes of Health and the Burden of Disease. NEJM
340: 1881-1887
[Abstract][Full Text]
Palmer, S., Byford, S., Raftery, J.
(1999). Economics Notes: Types of economic evaluation. BMJ
318: 1349-1349
[Full Text]
Palmer, S., Torgerson, D. J
(1999). Economics notes: Definitions of efficiency. BMJ
318: 1136-1136
[Full Text]
Alsarraf, R., Jung, C. J., Perkins, J., Crowley, C., Alsarraf, N. W., Gates, G. A.
(1999). Measuring the Indirect and Direct Costs of Acute Otitis Media. Arch Otolaryngol Head Neck Surg
125: 12-18
[Abstract][Full Text]
Russell, L. B.
(1998). Prevention and Medicare Costs. NEJM
339: 1158-1160
[Full Text]
Gage, B. F., Cardinalli, A. B., Owens, D. K.
(1998). Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation. Stroke
29: 1083-1091
[Abstract][Full Text]
Neumann, P. J.
(1998). Paying the Piper for Pharmacoeconomic Studies. Med Decis Making
18: S23-S26
Hornberger, J. C., Best, J. H., Garrison, L. P. Jr.
(1997). Cost-Effectiveness of Repeat Medical Procedures: Kidney Transplantation as an Example. Med Decis Making
17: 363-372
[Abstract]
Scharfstein, J. A., Paltiel, A. D., Freedberg, K. A.
(1997). The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients. Med Decis Making
17: 373-381
[Abstract]
Neumann, P. J., Zinner, D. E., Wright, J. C.
(1997). Are Methods for Estimating QALYs in Cost-Effectiveness Analyses Improving?. Med Decis Making
17: 402-408
[Abstract]
Fryback, D. G., Lawrence, W. F. JR
(1997). Dollars May Not Buy as Many QALYs as We Think:: A Problem with Defining Quality-of-life Adjustments. Med Decis Making
17: 276-284
[Abstract]
Soohoo, N., Schneider, J. A., Kaplan, R. M.
(1997). A Cost-Effectiveness Analysis of the Orphan Drug Cysteamine in the Treatment of Infantile Cystinosis. Med Decis Making
17: 193-198
[Abstract]
Johannesson, M., Jonsson, B., Kjekshus, J., Olsson, A. G., Pedersen, T. R., Wedel, H., The Scandinavian Simvastatin Survival Study Group,
(1997). Cost Effectiveness of Simvastatin Treatment to Lower Cholesterol Levels in Patients with Coronary Heart Disease. NEJM
336: 332-336
[Abstract][Full Text]
Hlatky, M. A., Rogers, W. J., Johnstone, I., Boothroyd, D., Brooks, M. M., Pitt, B., Reeder, G., Ryan, T., Smith, H., Whitlow, P., Wiens, R., Mark, D. B., Rosen, A. D., Detre, K., Frye, R. L., The Bypass Angioplasty Revascularization Investiga,
(1997). Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery. NEJM
336: 92-99
[Abstract][Full Text]
Sonnenberg, F. A.
(1996). Immunoglobulin Therapy for IgA Nephropathy: When Is Cost Saving Enough?. Med Decis Making
16: 420-421
Harrow, B. S., Lasater, T. M., Gans, K. M.
(1996). A Strategy for Accurate Collection of Incremental Cost Data for Cost-Effectiveness Analyses in Field Trials: Pawtucket's Minimal Contact Cholesterol Education Intervention. Eval Rev
20: 275-290
[Abstract]
Freedberg, K. A., Hardy, W. D., Holzman, R. S., Tosteson, A. N.A., Craven, D. E.
(1996). Validating Literature-based Models with Direct Clinical Trial Results: The Cost-Effectiveness of Secondary Prophylaxis for PCP in AIDS Patients. Med Decis Making
16: 29-35
[Abstract]
Javitt, J. C., Aiello, L. P.
(1996). Cost-Effectiveness of Detecting and Treating Diabetic Retinopathy. ANN INTERN MED
124: 164-169
[Abstract][Full Text]
Chapman, G. B., Elstein, A. S.
(1995). Valuing the Future: Temporal Discounting of Health and Money. Med Decis Making
15: 373-386
[Abstract]
Xiaodong Kong, S., Stubbings, J.
(1995). Assessing the Economic Value of Pharmaceutical Products and Services. Journal of Pharmacy Practice
8: 143-155
[Abstract]
Johnson, J. A., Coons, S. J.
(1995). Evaluation of Published Pharmacoeconomic Studies. Journal of Pharmacy Practice
8: 156-166
[Abstract]
Nord, E.
(1995). The Person-trade-off Approach to Valuing Health Care Programs. Med Decis Making
15: 201-208
[Abstract]
Gardiner, J., Hogan, A., Holmes-Rovner, M., Rovner, D., Griffith, L., Kupersmith, J.
(1995). Confidence Intervals for Cost - Effectiveness Ratios. Med Decis Making
15: 254-263
[Abstract]
Etchason, J., Petz, L., Keeler, E., Calhoun, L., Kleinman, S., Snider, C., Fink, A., Brook, R.
(1995). The Cost Effectiveness of Preoperative Autologous Blood Donations. NEJM
332: 719-724
[Abstract][Full Text]
van Oortmarssen, G., Boer, R., Habbema, J.
(1995). Modelling issues in cancer screening. Stat Methods Med Res
4: 33-54
[Abstract]
Carey, J. S., Cukingnan, R. A., Singer, L. K. M.
(1995). Health Status After Myocardial Revascularization: Inferior Results in Women. Ann. Thorac. Surg.
59: 112-117
[Abstract][Full Text]
Redelmeier, D. A., Heller, D. N., Weinstein, M. C.
(1994). Time Preference in Medical Economics: Science or Religion?. Med Decis Making
14: 301-303
Previous
